The National Service of Health and Agri-Food Quality (Senasa) launched a new procedure for authorization by equivalence This will streamline the importation and approval of veterinary products registered abroad, without compromising health safety.
The measure, made official today (16.05.2025/333/2025) through Resolution XNUMX/XNUMX, is part of Argentina's commitment to the regional regulatory harmonization promoted by CAMEVET—the technical body of the World Organization for Animal Health (WHO)—and is aligned with the established principles of regulatory simplification, aimed at "more agile, efficient, and transparent public management."
According to the rule, the new regime will allow the recognition of health records issued by countries that have equivalent regulatory standardsAmong them are United States, Japan, Sweden, Switzerland, Israel, Canada, Austria, Germany, France, United Kingdom, Netherlands, Belgium, Uruguay, Denmark, Spain, and Italy.
Reduction of time and costs
The national government highlighted the positive economic impact of this measure. According to the Minister of Economy, Luis Caputo, the new procedure will not only facilitate access to veterinary supplies with international standards, but will also significantly shorten approval times, which will go from taking up to two years to a maximum of two. 90 working days administrative.
Caputo added that this streamlining will also help reduce the costs of strategic products, such as the foot-and-mouth disease vaccine. “In Argentina, the dose is priced at around $1,20 ($1,36 in December 2023), while in neighboring countries such as Paraguay and Uruguay the value is around $0,37 and $0,50, respectively,” he detailed in his social network.
Scope
To operationalize this measure and ensure compliance with health standards, SENASA established the guidelines for the equivalence authorization procedure, which will be applicable to all veterinary medicines, except those who:
- Contain agents intended for exotic or eradicated diseases not included in national health plans.
- Include attenuated strains not circulating in the country.
- Contain genetically modified organisms (GMOs) or recombinants.
- They are diagnostic kits outside of official health programs.
The is already in force since its publication in the Official Gazette. For technical details and required documentation, please consult the full text.
Aduana News is the first Argentine customs newspaper to launch its digital version. With 20 years of experience, its publications and initiatives aim to provide the most relevant knowledge on customs issues in order to contribute to safe trade in the region.
